(Q34838292)

4 August 2017

1 reference

title

Adipogenesis and fat-cell function in obesity and diabetes (English)

1 reference

4 August 2017

0 references

1 reference

0 references

Heidi S Camp

1

1 reference

4 August 2017

Delin Ren

series ordinal

2

1 reference

4 August 2017

Todd Leff

series ordinal

3

1 reference

4 August 2017

publication date

1 September 2002

1 reference

Trends in Molecular Medicine

4 August 2017

published in

1 reference

4 August 2017

volume

8

1 reference

4 August 2017

issue

9

1 reference

4 August 2017

page(s)

442-447

1 reference

The continuing epidemics of obesity and diabetes in the United States

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Deterioration of the metabolic risk profile in women. Respective contributions of impaired glucose tolerance and visceral fat accumulation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

1 reference

7 January 2021

Hyperleptinemia is more closely associated with adipose cell hypertrophy than with adipose tissue hyperplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Activation of peroxisome proliferator-activated receptor gamma bypasses the function of the retinoblastoma protein in adipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Role of PPARgamma in regulating a cascade expression of cyclin-dependent kinase inhibitors, p18(INK4c) and p21(Waf1/Cip1), during adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Analysis of cell cycle arrest in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Molecular regulation of adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The role of C/EBP genes in adipocyte differentiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Role of the CCAAT/enhancer binding protein-alpha transcription factor in the glucocorticoid stimulation of p21waf1/cip1 gene promoter activity in growth-arrested rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Retinoic acid blocks adipogenesis by inhibiting C/EBPbeta-mediated transcription

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Defective adipocyte differentiation in mice lacking the C/EBPbeta and/or C/EBPdelta gene

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Tissue distribution and quantification of the expression of mRNAs of peroxisome proliferator-activated receptors and liver X receptor-alpha in humans: no alteration in adipose tissue of obese and NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPARgamma knockdown by engineered transcription factors: exogenous PPARgamma2 but not PPARgamma1 reactivates adipogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Ligand-independent activation domain in the N terminus of peroxisome proliferator-activated receptor gamma (PPARgamma). Differential activity of PPARgamma1 and -2 isoforms and influence of insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPAR gamma is required for placental, cardiac, and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Impaired Energy Homeostasis in C/EBPα Knockout Mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Ectopic expression of the CCAAT/enhancer-binding protein alpha promotes the adipogenic program in a variety of mouse fibroblastic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Reconstitution of insulin-sensitive glucose transport in fibroblasts requires expression of both PPARgamma and C/EBPalpha.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Peroxisome proliferator-activated receptor gamma and metabolic disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts type II diabetes independent of insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Effect of troglitazone on body fat distribution in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Efficacy of troglitazone on body fat distribution in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

A novel heterozygous mutation in peroxisome proliferator-activated receptor-gamma gene in a patient with familial partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Insulin resistance in human partial lipodystrophy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor gamma

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

AdipoQ is a novel adipose-specific gene dysregulated in obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Genomewide search for type 2 diabetes-susceptibility genes in French whites: evidence for a novel susceptibility locus for early-onset diabetes on chromosome 3q27-qter and independent replication of a type 2-diabetes locus on chromosome 1q21-q24.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Quantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Resistin and obesity-associated insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4914%2802%2902396-1

7 January 2021

10.1016/S1471-4914(02)02396-1

Identifiers

DOI

1 reference

4 August 2017

1 reference